http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-1211373-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_49d10e350f03a5e0edcba0f3cd3480c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4655b70cbfba352025a1d2393b449e77
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7064
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-708
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7072
filingDate 1983-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1986-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c5d4107be4e79074896a58e6b4df736
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ceddd7d7fbdff08effd6f099ed18fade
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b08602275d65875ed86efce7dc799fe7
publicationDate 1986-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-1211373-A
titleOfInvention Pharmaceutical compositions based on xylosides and lyxosides of purine and pyrimidine bases
abstract ABSTRACT "PHARMACEUTICAL COMPOSITIONS BASED ON XYLOSIDES AND LYXOSIDES OF PURINE AND PYRIMIDINE BASES" Pharmaceutical compositions which contain a xyloside or a lyxoside of a purine or pyrimidine base selected from the following compounds: 1-(.beta.-D-xylofuranosyl)-cytosine, 1-(.beta.-D-xylofuranosyl)-thymine, 9-(.alpha.-D-xylofuranosyl)-adenine, 9-(.alpha.-D-xylofuranosyl)-guanine, 1-(.alpha.-D-xylofuranosyl)-cytosine, 1-(.alpha.-D-xylofuranosyl)-thymine, 9-(.alpha.-D-lyxofuranosyl)-adenine, 9-(.beta.-D-lyxofuranosyl)-guanine, 1-(.beta.-D-lyxofuranosyl)-cytosine, 1-(.beta.-D-lyxofuranosyl)-thymine, 9-(.alpha.-D-lyxofuranosyl)-adenine, 9-(.alpha.-D-lyxofuranosyl)-guanine, 1-(.alpha.-D-lyxofuranosyl)-cytosine and 1-(.alpha.-D-lyxofuranosyl)-thymine, have been found to be useful in therapy for treating various viral diseases.
priorityDate 1982-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10245
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID2725057
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559203
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1044
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID644176
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135191
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65367
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410062813
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10245
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557654
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397498
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID2725057
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397502
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523447
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419593837
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412563225
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID644160

Total number of triples: 45.